SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-10-083044
Filing Date
2010-09-01
Accepted
2010-09-01 15:35:58
Documents
5
Effectiveness Date
2010-09-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 c05559sv8.htm S-8 51342
2 EXHIBIT 4.3 c05559exv4w3.htm EX-4.3 5524
3 EXHIBIT 5.1 c05559exv5w1.htm EX-5.1 5465
4 EXHIBIT 23.1 c05559exv23w1.htm EX-23.1 1817
5 GRAPHIC c05559c0555900.gif GRAPHIC 2169
  Complete submission text file 0000950123-10-083044.txt   68710
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-169140 | Film No.: 101052483
SIC: 2836 Biological Products, (No Diagnostic Substances)